United States Biotechnology & Medical Research

Scholar Rock Holding Corporation (SRRK)

Scholar Rock Holding Corporation experienced significant insider trading activity recently, highlighted by Srinivas Akkaraju acquiring shares worth approximately 12 million dollars in late October. While other directors executed planned sales earlier, this substantial buying represents the primary movement. These transactions occurred following the August results financiers, amidst a stock price decline of 13.3 percent over ninety days.
Ticker: SRRK Exchange: NSM
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Scholar Rock Holding Corporation. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
3.6
AKKARAJU SRINIVAS Non-Executive Director
Transaction date
Purchase
Price
79.13
Quantity 37,569 +5.1%
Value US$4,833,276
3.6
AKKARAJU SRINIVAS Non-Executive Director
Transaction date
Purchase
Price
478.37
Quantity 43,623 +31.6%
Value US$3,381,677
3.6
AKKARAJU SRINIVAS Non-Executive Director
Transaction date
Purchase
Price
309.62
Quantity 84,216 -13.0%
Value US$3,198,898
3.6
AKKARAJU SRINIVAS Non-Executive Director
Transaction date
Purchase
Price
41.82
Quantity 1,000 +0.0%
Value US$100,000
3.6
AKKARAJU SRINIVAS Non-Executive Director
Transaction date
Purchase
Price
41.31
Quantity 1,000 +17.7%
Value US$100,000
3.6
AKKARAJU SRINIVAS Non-Executive Director
Transaction date
Purchase
Price
41.31
Quantity 1,000 +0.7%
Value US$100,000
1.5
Katie Peng Director Non-Executive Director
Transaction date
Proposed sale
Price
48.32
Quantity 1,006
Value US$48,610
3.4
Mohammed Qatanani Officer Officer
Transaction date
Proposed sale
Price
54.68
Quantity 11,704
Value US$639,975
FLIER JEFFREY S. Non-Executive Director
Transaction date
Planned sale
Price
54.88
Quantity 15 -0.1%
Value US$823
FLIER JEFFREY S. Non-Executive Director
Transaction date
Planned sale
Price
54.24
Quantity 1,470 -5.0%
Value US$79,728
FLIER JEFFREY S. Non-Executive Director
Transaction date
Planned sale
Price
53.53
Quantity 1,568 -5.1%
Value US$83,939
3.2
Burow Kristina Non-Executive Director
Transaction date
Planned sale
Price
54.28
Quantity 948 -0.8%
Value US$51,459
3.2
Burow Kristina Non-Executive Director
Transaction date
Planned sale
Price
53.49
Quantity 2,105 -1.8%
Value US$112,605
Gilman Michael Non-Executive Director
Transaction date
Planned sale
Price
54.81
Quantity 43 -0.1%
Value US$2,357
Gilman Michael Non-Executive Director
Transaction date
Planned sale
Price
54.23
Quantity 1,155 -1.9%
Value US$62,631
Gilman Michael Non-Executive Director
Transaction date
Planned sale
Price
53.54
Quantity 1,346 -2.2%
Value US$72,070
1.5
Peng Katie Non-Executive Director
Transaction date
Planned sale
Price
54.96
Quantity 21 -0.1%
Value US$1,154
1.5
Peng Katie Non-Executive Director
Transaction date
Planned sale
Price
54.25
Quantity 2,437 -6.6%
Value US$132,214
1.5
Peng Katie Non-Executive Director
Transaction date
Planned sale
Price
53.56
Quantity 2,988 -7.5%
Value US$160,037
Reed Joshua Non-Executive Director
Transaction date
Planned sale
Price
54.28
Quantity 948 -4.6%
Value US$51,459
Reed Joshua Non-Executive Director
Transaction date
Planned sale
Price
53.50
Quantity 2,105 -9.3%
Value US$112,609
Joshua Reed Director Non-Executive Director
Transaction date
Proposed sale
Price
54.79
Quantity 3,053
Value US$167,274
Jeffrey S. Flier Director Non-Executive Director
Transaction date
Proposed sale
Price
54.79
Quantity 3,053
Value US$167,274
3.2
Kristina Burow Director Non-Executive Director
Transaction date
Proposed sale
Price
54.79
Quantity 3,053
Value US$167,274
Michael Gilman Director Non-Executive Director
Transaction date
Proposed sale
Price
54.79
Quantity 2,544
Value US$139,385
1.5
Katie Peng Director Non-Executive Director
Transaction date
Proposed sale
Price
54.79
Quantity 5,446
Value US$298,386
1.4
Woods Keith Chief Operating Officer Officer
Transaction date
Sale
Price
49.57
Quantity 10,220 -1.6%
Value US$506,651
2.4
Vaishnaw Akshay President of R&D Executive Director
Transaction date
Sale
Price
49.57
Quantity 12,246 -1.9%
Value US$607,089
2.7
Sinha Vikas Chief Financial Officer Officer
Transaction date
Sale
Price
49.57
Quantity 10,410 -1.7%
Value US$516,071
2.9
Hallal David Chief Executive Officer Executive Director
Transaction date
Sale
Price
49.57
Quantity 30,615 -1.8%
Value US$1,517,723
3.4
Mohammed Qatanani Officer Officer
Transaction date
Proposed sale
Price
50.01
Quantity 23,408
Value US$1,170,634
3.4
Qatanani Mo CHIEF SCIENTIFIC OFFICER Officer
Transaction date
Planned sale
Price
48.48
Quantity 200 -0.2%
Value US$9,696
3.4
Qatanani Mo CHIEF SCIENTIFIC OFFICER Officer
Transaction date
Planned sale
Price
47.86
Quantity 857 -0.9%
Value US$41,015
3.4
Qatanani Mo CHIEF SCIENTIFIC OFFICER Officer
Transaction date
Planned sale
Price
46.94
Quantity 7,427 -6.9%
Value US$348,640
3.4
Mohammed Qatanani Officer Officer
Transaction date
Proposed sale
Price
48.32
Quantity 8,484
Value US$409,947
2.9
Marantz Jing L. CHIEF MEDICAL OFFICER Officer
Transaction date
Sale
Price
46.53
Quantity 4,157 -3.2%
Value US$193,418
3.3
Ho Junlin GENERAL COUNSEL Officer
Transaction date
Sale
Price
46.53
Quantity 9,580 -3.8%
Value US$445,740
3.1
Parlavecchio Caryn CHRO Officer
Transaction date
Sale
Price
46.53
Quantity 9,035 -5.1%
Value US$420,382
3.4
Qatanani Mo CHIEF SCIENTIFIC OFFICER Officer
Transaction date
Sale
Price
46.53
Quantity 7,989 -7.0%
Value US$371,714
3.4
Qatanani Mo CHIEF SCIENTIFIC OFFICER Officer
Transaction date
Planned sale
Price
46.85
Quantity 12,779 -13.0%
Value US$598,749
3.4
Qatanani Mo CHIEF SCIENTIFIC OFFICER Officer
Transaction date
Planned sale
Price
45.87
Quantity 2,119 -2.1%
Value US$97,189
3.4
Mohammed Qatanani Officer Officer
Transaction date
Proposed sale
Price
46.05
Quantity 14,898
Value US$686,053
2.9
Marantz Jing L. CHIEF MEDICAL OFFICER Officer
Transaction date
Sale
Price
44.48
Quantity 5,798 -5.7%
Value US$257,882
3.3
Ho Junlin GENERAL COUNSEL Officer
Transaction date
Sale
Price
44.48
Quantity 8,016 -3.6%
Value US$356,533
3.4
Qatanani Mo CHIEF SCIENTIFIC OFFICER Officer
Transaction date
Sale
Price
44.48
Quantity 8,406 -7.7%
Value US$373,880
3.1
Parlavecchio Caryn CHRO Officer
Transaction date
Sale
Price
44.48
Quantity 6,600 -4.2%
Value US$293,553
3.4
Qatanani Mo CHIEF SCIENTIFIC OFFICER Officer
Transaction date
Planned sale
Price
45.20
Quantity 13,112 -10.7%
Value US$592,611
2.7
Sinha Vikas Chief Financial Officer Officer
Transaction date
Sale
Price
42.70
Quantity 16,755 -2.8%
Value US$715,438
2.9
Hallal David Chief Executive Officer Executive Director
Transaction date
Sale
Price
42.70
Quantity 57,450 -3.6%
Value US$2,453,115
1.4
Woods Keith Chief Operating Officer Officer
Transaction date
Sale
Price
42.70
Quantity 16,746 -2.8%
Value US$715,054
2.4
Vaishnaw Akshay President of R&D Executive Director
Transaction date
Sale
Price
42.70
Quantity 20,438 -3.3%
Value US$872,703
1.5
Peng Katie Non-Executive Director
Transaction date
Sale
Price
44.63
Quantity 280 -0.8%
Value US$12,498
1.5
Peng Katie Non-Executive Director
Transaction date
Sale
Price
43.88
Quantity 726 -2.1%
Value US$31,854
1.5
Katie Peng Director Non-Executive Director
Transaction date
Proposed sale
Price
45.24
Quantity 1,006
Value US$45,511
3.4
Qatanani Mo CHIEF SCIENTIFIC OFFICER Officer
Transaction date
Planned sale
Price
45.21
Quantity 136,462 -55.6%
Value US$6,169,788
3.4
Mohammed Qatanani Officer Officer
Transaction date
Proposed sale
Price
43.01
Quantity 149,574
Value US$6,433,178
3.6
AKKARAJU SRINIVAS Non-Executive Director
Transaction date
Purchase
Price
40.97
Quantity 4,403 +0.8%
Value US$180,391
3.6
AKKARAJU SRINIVAS Non-Executive Director
Transaction date
Purchase
Price
40.18
Quantity 12,400 +2.4%
Value US$498,232
3.6
AKKARAJU SRINIVAS Non-Executive Director
Transaction date
Purchase
Price
39.31
Quantity 12,796 +2.6%
Value US$503,011
3.6
AKKARAJU SRINIVAS Non-Executive Director
Transaction date
Purchase
Price
39.52
Quantity 13,748 +2.8%
Value US$543,321
3.6
AKKARAJU SRINIVAS Non-Executive Director
Transaction date
Purchase
Price
38.68
Quantity 80,863 +19.9%
Value US$3,127,781
3.6
AKKARAJU SRINIVAS Non-Executive Director
Transaction date
Purchase
Price
37.89
Quantity 18,414 +4.8%
Value US$697,706
3.6
AKKARAJU SRINIVAS Non-Executive Director
Transaction date
Purchase
Price
37.42
Quantity 319,700 +472.1%
Value US$11,963,174
3.6
AKKARAJU SRINIVAS Non-Executive Director
Transaction date
Purchase
Price
36.74
Quantity 56,703 +515.0%
Value US$2,083,268
3.6
AKKARAJU SRINIVAS Non-Executive Director
Transaction date
Purchase
Price
35.61
Quantity 11,011 New position
Value US$392,102
3.4
Qatanani Mo CHIEF SCIENTIFIC OFFICER Officer
Transaction date
Planned sale
Price
30.67
Quantity 3,353 -3.0%
Value US$102,846
3.4
Mohammed Qatanani Officer Officer
Transaction date
Proposed sale
Price
30.67
Quantity 3,353
Value US$102,846
1.5
Peng Katie Non-Executive Director
Transaction date
Planned sale
Price
33.20
Quantity 76 -0.2%
Value US$2,523
1.5
Peng Katie Non-Executive Director
Transaction date
Planned sale
Price
32.48
Quantity 930 -2.7%
Value US$30,203
3.4
Qatanani Mo CHIEF SCIENTIFIC OFFICER Officer
Transaction date
Sale
Price
33.52
Quantity 3,178 -2.8%
Value US$106,527
1.5
Katie Peng Director Non-Executive Director
Transaction date
Proposed sale
Price
32.53
Quantity 1,006
Value US$32,726
3.1
Parlavecchio Caryn CHRO Officer
Transaction date
Sale
Price
31.17
Quantity 2,178 -1.4%
Value US$67,880
FLIER JEFFREY S. Non-Executive Director
Transaction date
Planned sale
Price
40.02
Quantity 11,136 -100.0%
Value US$445,688
3.4
Qatanani Mo CHIEF SCIENTIFIC OFFICER Officer
Transaction date
Planned sale
Price
34.44
Quantity 24,066 -17.2%
Value US$828,898
3.4
Mohammed Qatanani Officer Officer
Transaction date
Proposed sale
Price
35.48
Quantity 24,066
Value US$853,862
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-10-27 2026-10-26 B Purchase
3.6
AKKARAJU SRINIVAS
Non-Executive Director
37,569 +5.1%
79.13
US$4,833,276 		37,569 +5.1% 79.13 US$4,833,276
2026-10-27 2026-10-26 B Purchase
3.6
AKKARAJU SRINIVAS
Non-Executive Director
43,623 +31.6%
478.37
US$3,381,677 		43,623 +31.6% 478.37 US$3,381,677
2026-10-27 2026-10-23 B Purchase
3.6
AKKARAJU SRINIVAS
Non-Executive Director
84,216 -13.0%
309.62
US$3,198,898 		84,216 -13.0% 309.62 US$3,198,898
2026-10-27 2026-10-23 B Purchase
3.6
AKKARAJU SRINIVAS
Non-Executive Director
1,000 +0.0%
41.82
US$100,000 		1,000 +0.0% 41.82 US$100,000
2026-10-27 2026-10-23 B Purchase
3.6
AKKARAJU SRINIVAS
Non-Executive Director
1,000 +17.7%
41.31
US$100,000 		1,000 +17.7% 41.31 US$100,000
2026-10-27 2026-10-23 B Purchase
3.6
AKKARAJU SRINIVAS
Non-Executive Director
1,000 +0.7%
41.31
US$100,000 		1,000 +0.7% 41.31 US$100,000
2026-10-01 2026-10-01 PrS Proposed sale
1.5
Katie Peng

Director

Non-Executive Director
1,006
48.32
US$48,610 		1,006 48.32 US$48,610
2026-07-06 2026-07-06 PrS Proposed sale
3.4
Mohammed Qatanani

Officer

Officer
11,704
54.68
US$639,975 		11,704 54.68 US$639,975
2026-07-06 2026-07-01 PlS Planned sale
FLIER JEFFREY S.
Non-Executive Director
15 -0.1%
54.88
US$823 		15 -0.1% 54.88 US$823
2026-07-06 2026-07-01 PlS Planned sale
FLIER JEFFREY S.
Non-Executive Director
1,470 -5.0%
54.24
US$79,728 		1,470 -5.0% 54.24 US$79,728
2026-07-06 2026-07-01 PlS Planned sale
FLIER JEFFREY S.
Non-Executive Director
1,568 -5.1%
53.53
US$83,939 		1,568 -5.1% 53.53 US$83,939
2026-07-06 2026-07-01 PlS Planned sale
3.2
Burow Kristina
Non-Executive Director
948 -0.8%
54.28
US$51,459 		948 -0.8% 54.28 US$51,459
2026-07-06 2026-07-01 PlS Planned sale
3.2
Burow Kristina
Non-Executive Director
2,105 -1.8%
53.49
US$112,605 		2,105 -1.8% 53.49 US$112,605
2026-07-06 2026-07-01 PlS Planned sale
Gilman Michael
Non-Executive Director
43 -0.1%
54.81
US$2,357 		43 -0.1% 54.81 US$2,357
2026-07-06 2026-07-01 PlS Planned sale
Gilman Michael
Non-Executive Director
1,155 -1.9%
54.23
US$62,631 		1,155 -1.9% 54.23 US$62,631
2026-07-06 2026-07-01 PlS Planned sale
Gilman Michael
Non-Executive Director
1,346 -2.2%
53.54
US$72,070 		1,346 -2.2% 53.54 US$72,070
2026-07-06 2026-07-01 PlS Planned sale
1.5
Peng Katie
Non-Executive Director
21 -0.1%
54.96
US$1,154 		21 -0.1% 54.96 US$1,154
2026-07-06 2026-07-01 PlS Planned sale
1.5
Peng Katie
Non-Executive Director
2,437 -6.6%
54.25
US$132,214 		2,437 -6.6% 54.25 US$132,214
2026-07-06 2026-07-01 PlS Planned sale
1.5
Peng Katie
Non-Executive Director
2,988 -7.5%
53.56
US$160,037 		2,988 -7.5% 53.56 US$160,037
2026-07-06 2026-07-01 PlS Planned sale
Reed Joshua
Non-Executive Director
948 -4.6%
54.28
US$51,459 		948 -4.6% 54.28 US$51,459
2026-07-06 2026-07-01 PlS Planned sale
Reed Joshua
Non-Executive Director
2,105 -9.3%
53.50
US$112,609 		2,105 -9.3% 53.50 US$112,609
2026-07-01 2026-07-01 PrS Proposed sale
Joshua Reed

Director

Non-Executive Director
3,053
54.79
US$167,274 		3,053 54.79 US$167,274
2026-07-01 2026-07-01 PrS Proposed sale
Jeffrey S. Flier

Director

Non-Executive Director
3,053
54.79
US$167,274 		3,053 54.79 US$167,274
2026-07-01 2026-07-01 PrS Proposed sale
3.2
Kristina Burow

Director

Non-Executive Director
3,053
54.79
US$167,274 		3,053 54.79 US$167,274
2026-07-01 2026-07-01 PrS Proposed sale
Michael Gilman

Director

Non-Executive Director
2,544
54.79
US$139,385 		2,544 54.79 US$139,385
2026-07-01 2026-07-01 PrS Proposed sale
1.5
Katie Peng

Director

Non-Executive Director
5,446
54.79
US$298,386 		5,446 54.79 US$298,386
2026-04-20 2026-04-16 S Sale
1.4
Woods Keith

Chief Operating Officer

Officer
10,220 -1.6%
49.57
US$506,651 		10,220 -1.6% 49.57 US$506,651
2026-04-20 2026-04-16 S Sale
2.4
Vaishnaw Akshay

President of R&D

Executive Director
12,246 -1.9%
49.57
US$607,089 		12,246 -1.9% 49.57 US$607,089
2026-04-20 2026-04-16 S Sale
2.7
Sinha Vikas

Chief Financial Officer

Officer
10,410 -1.7%
49.57
US$516,071 		10,410 -1.7% 49.57 US$516,071
2026-04-20 2026-04-16 S Sale
2.9
Hallal David

Chief Executive Officer

Executive Director
30,615 -1.8%
49.57
US$1,517,723 		30,615 -1.8% 49.57 US$1,517,723
2026-04-06 2026-04-06 PrS Proposed sale
3.4
Mohammed Qatanani

Officer

Officer
23,408
50.01
US$1,170,634 		23,408 50.01 US$1,170,634
2026-02-25 2026-02-23 PlS Planned sale
3.4
Qatanani Mo

CHIEF SCIENTIFIC OFFICER

Officer
200 -0.2%
48.48
US$9,696 		200 -0.2% 48.48 US$9,696
2026-02-25 2026-02-23 PlS Planned sale
3.4
Qatanani Mo

CHIEF SCIENTIFIC OFFICER

Officer
857 -0.9%
47.86
US$41,015 		857 -0.9% 47.86 US$41,015
2026-02-25 2026-02-23 PlS Planned sale
3.4
Qatanani Mo

CHIEF SCIENTIFIC OFFICER

Officer
7,427 -6.9%
46.94
US$348,640 		7,427 -6.9% 46.94 US$348,640
2026-02-23 2026-02-23 PrS Proposed sale
3.4
Mohammed Qatanani

Officer

Officer
8,484
48.32
US$409,947 		8,484 48.32 US$409,947
2026-02-19 2026-02-17 S Sale
2.9
Marantz Jing L.

CHIEF MEDICAL OFFICER

Officer
4,157 -3.2%
46.53
US$193,418 		4,157 -3.2% 46.53 US$193,418
2026-02-19 2026-02-17 S Sale
3.3
Ho Junlin

GENERAL COUNSEL

Officer
9,580 -3.8%
46.53
US$445,740 		9,580 -3.8% 46.53 US$445,740
2026-02-19 2026-02-17 S Sale
3.1
Parlavecchio Caryn

CHRO

Officer
9,035 -5.1%
46.53
US$420,382 		9,035 -5.1% 46.53 US$420,382
2026-02-19 2026-02-17 S Sale
3.4
Qatanani Mo

CHIEF SCIENTIFIC OFFICER

Officer
7,989 -7.0%
46.53
US$371,714 		7,989 -7.0% 46.53 US$371,714
2026-01-23 2026-01-22 PlS Planned sale
3.4
Qatanani Mo

CHIEF SCIENTIFIC OFFICER

Officer
12,779 -13.0%
46.85
US$598,749 		12,779 -13.0% 46.85 US$598,749
2026-01-23 2026-01-22 PlS Planned sale
3.4
Qatanani Mo

CHIEF SCIENTIFIC OFFICER

Officer
2,119 -2.1%
45.87
US$97,189 		2,119 -2.1% 45.87 US$97,189
2026-01-22 2026-01-22 PrS Proposed sale
3.4
Mohammed Qatanani

Officer

Officer
14,898
46.05
US$686,053 		14,898 46.05 US$686,053
2026-01-21 2026-01-16 S Sale
2.9
Marantz Jing L.

CHIEF MEDICAL OFFICER

Officer
5,798 -5.7%
44.48
US$257,882 		5,798 -5.7% 44.48 US$257,882
2026-01-21 2026-01-16 S Sale
3.3
Ho Junlin

GENERAL COUNSEL

Officer
8,016 -3.6%
44.48
US$356,533 		8,016 -3.6% 44.48 US$356,533
2026-01-21 2026-01-16 S Sale
3.4
Qatanani Mo

CHIEF SCIENTIFIC OFFICER

Officer
8,406 -7.7%
44.48
US$373,880 		8,406 -7.7% 44.48 US$373,880
2026-01-21 2026-01-16 S Sale
3.1
Parlavecchio Caryn

CHRO

Officer
6,600 -4.2%
44.48
US$293,553 		6,600 -4.2% 44.48 US$293,553
2026-01-16 2026-01-14 PlS Planned sale
3.4
Qatanani Mo

CHIEF SCIENTIFIC OFFICER

Officer
13,112 -10.7%
45.20
US$592,611 		13,112 -10.7% 45.20 US$592,611
2026-01-15 2026-01-13 S Sale
2.7
Sinha Vikas

Chief Financial Officer

Officer
16,755 -2.8%
42.70
US$715,438 		16,755 -2.8% 42.70 US$715,438
2026-01-15 2026-01-13 S Sale
2.9
Hallal David

Chief Executive Officer

Executive Director
57,450 -3.6%
42.70
US$2,453,115 		57,450 -3.6% 42.70 US$2,453,115
2026-01-15 2026-01-13 S Sale
1.4
Woods Keith

Chief Operating Officer

Officer
16,746 -2.8%
42.70
US$715,054 		16,746 -2.8% 42.70 US$715,054
2026-01-15 2026-01-13 S Sale
2.4
Vaishnaw Akshay

President of R&D

Executive Director
20,438 -3.3%
42.70
US$872,703 		20,438 -3.3% 42.70 US$872,703
2025-12-18 2025-12-16 S Sale
1.5
Peng Katie
Non-Executive Director
280 -0.8%
44.63
US$12,498 		280 -0.8% 44.63 US$12,498
2025-12-18 2025-12-16 S Sale
1.5
Peng Katie
Non-Executive Director
726 -2.1%
43.88
US$31,854 		726 -2.1% 43.88 US$31,854
2025-12-16 2025-12-16 PrS Proposed sale
1.5
Katie Peng

Director

Non-Executive Director
1,006
45.24
US$45,511 		1,006 45.24 US$45,511
2025-12-05 2025-12-04 PlS Planned sale
3.4
Qatanani Mo

CHIEF SCIENTIFIC OFFICER

Officer
136,462 -55.6%
45.21
US$6,169,788 		136,462 -55.6% 45.21 US$6,169,788
2025-12-04 2025-12-04 PrS Proposed sale
3.4
Mohammed Qatanani

Officer

Officer
149,574
43.01
US$6,433,178 		149,574 43.01 US$6,433,178
2025-12-16 2025-10-07 B Purchase
3.6
AKKARAJU SRINIVAS
Non-Executive Director
4,403 +0.8%
40.97
US$180,391 		4,403 +0.8% 40.97 US$180,391
2025-12-16 2025-10-07 B Purchase
3.6
AKKARAJU SRINIVAS
Non-Executive Director
12,400 +2.4%
40.18
US$498,232 		12,400 +2.4% 40.18 US$498,232
2025-12-16 2025-10-07 B Purchase
3.6
AKKARAJU SRINIVAS
Non-Executive Director
12,796 +2.6%
39.31
US$503,011 		12,796 +2.6% 39.31 US$503,011
2025-10-07 2025-10-06 B Purchase
3.6
AKKARAJU SRINIVAS
Non-Executive Director
13,748 +2.8%
39.52
US$543,321 		13,748 +2.8% 39.52 US$543,321
2025-10-07 2025-10-06 B Purchase
3.6
AKKARAJU SRINIVAS
Non-Executive Director
80,863 +19.9%
38.68
US$3,127,781 		80,863 +19.9% 38.68 US$3,127,781
2025-10-07 2025-10-06 B Purchase
3.6
AKKARAJU SRINIVAS
Non-Executive Director
18,414 +4.8%
37.89
US$697,706 		18,414 +4.8% 37.89 US$697,706
2025-10-07 2025-10-03 B Purchase
3.6
AKKARAJU SRINIVAS
Non-Executive Director
319,700 +472.1%
37.42
US$11,963,174 		319,700 +472.1% 37.42 US$11,963,174
2025-10-07 2025-10-03 B Purchase
3.6
AKKARAJU SRINIVAS
Non-Executive Director
56,703 +515.0%
36.74
US$2,083,268 		56,703 +515.0% 36.74 US$2,083,268
2025-10-07 2025-10-03 B Purchase
3.6
AKKARAJU SRINIVAS
Non-Executive Director
11,011 New position
35.61
US$392,102 		11,011 New position 35.61 US$392,102
2025-09-24 2025-09-22 PlS Planned sale
3.4
Qatanani Mo

CHIEF SCIENTIFIC OFFICER

Officer
3,353 -3.0%
30.67
US$102,846 		3,353 -3.0% 30.67 US$102,846
2025-09-22 2025-09-22 PrS Proposed sale
3.4
Mohammed Qatanani

Officer

Officer
3,353
30.67
US$102,846 		3,353 30.67 US$102,846
2025-09-17 2025-09-16 PlS Planned sale
1.5
Peng Katie
Non-Executive Director
76 -0.2%
33.20
US$2,523 		76 -0.2% 33.20 US$2,523
2025-09-17 2025-09-16 PlS Planned sale
1.5
Peng Katie
Non-Executive Director
930 -2.7%
32.48
US$30,203 		930 -2.7% 32.48 US$30,203
2025-09-17 2025-09-16 S Sale
3.4
Qatanani Mo

CHIEF SCIENTIFIC OFFICER

Officer
3,178 -2.8%
33.52
US$106,527 		3,178 -2.8% 33.52 US$106,527
2025-09-16 2025-09-16 PrS Proposed sale
1.5
Katie Peng

Director

Non-Executive Director
1,006
32.53
US$32,726 		1,006 32.53 US$32,726
2025-08-19 2025-08-18 S Sale
3.1
Parlavecchio Caryn

CHRO

Officer
2,178 -1.4%
31.17
US$67,880 		2,178 -1.4% 31.17 US$67,880
2025-07-18 2025-07-16 PlS Planned sale
FLIER JEFFREY S.
Non-Executive Director
11,136 -100.0%
40.02
US$445,688 		11,136 -100.0% 40.02 US$445,688
2025-07-10 2025-07-08 PlS Planned sale
3.4
Qatanani Mo

CHIEF SCIENTIFIC OFFICER

Officer
24,066 -17.2%
34.44
US$828,898 		24,066 -17.2% 34.44 US$828,898
2025-07-08 2025-07-08 PrS Proposed sale
3.4
Mohammed Qatanani

Officer

Officer
24,066
35.48
US$853,862 		24,066 35.48 US$853,862

See older Scholar Rock Holding Corporation insider trades

Plus unlocks the full transaction history.

See localized pricing at checkout
Unlock Scholar Rock Holding Corporation history with Plus

Billed monthly · Cancel anytime

Explore more

More insider trading research around Scholar Rock Holding Corporation

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America